State Street SPDR S&P Pharmaceuticals ETF

1. 01

   Volume 3.6× its 30-session average on 3 Nov 2026

   3 Nov 2026 volume of 728.4K shares was 3.6× the average of the 30 sessions before it (201.6K), as the price rose 1.1%. SPY traded 0.8× its own average that session.

   Daily volume against a 30-session baseline · as of 3 Nov 2026

2. 02

   Ahead of SPY over 1 year

   1 month: +3.9% (SPY −1.6%). 3 months: −6.7% (SPY −0.4%). 1 year: +32.5% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: XPH, SPY · as of 4 Nov 2026

3. 03

   Below its 50-day average, above its 200-day

   The 4 Nov 2026 close of $65.36 was 1.1% below its 50-day average ($66.10) and 5.6% above its 200-day average ($61.87). It has closed above the 200-day for 313 sessions, since 8 Aug 2025. The 50-day average crossed above the 200-day on 28 Aug 2025, 298 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   66% of the way up its 52-week range

   Closed at $65.36 on 4 Nov 2026: 12.1% below the 52-week high of $74.35 (19 Aug 2026) and 37.3% above the low of $47.60 (7 Nov 2025).

   Daily price bars, split-adjusted · as of 4 Nov 2026

5. 05

   Short interest at 8.8% of shares outstanding

   613.9K shares were sold short at the 15 Oct 2026 settlement, 8.8% of the 7.0M shares outstanding; covering them would take 2.3 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close